FDAnews
www.fdanews.com/articles/138318-st-jude-announces-fda-clearance-for-industry-first-neurostimulation-lead-delivery-system-for-the-management-of-chronic-pain

St. Jude Announces FDA Clearance for Industry-First Neurostimulation Lead Delivery System for the Management of Chronic Pain

July 12, 2011
St. Jude Medical announced the FDA clearance and limited market release of the Epiducer lead delivery system for neurostimulation therapy. This system allows physicians to place multiple neurostimulation leads through a single entry point.
Business Wire